ArticleNeuro-oncology advances

TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors.

Diana Cantero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.